Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$288K Buy
6,983
+4
+0.1% +$174 0.01% 805
2026
Q2
$298K Buy
6,979
+1,335
+24% +$59.7K 0.01% 805
2026
Q1
$272K Buy
5,644
+799
+16% +$37.3K 0.01% 773
2025
Q4
$235K Buy
4,845
+7
+0.1% +$347 0.01% 816
2025
Q3
$228K Buy
4,838
+323
+7% +$15.6K 0.02% 626
2025
Q2
$218K Buy
4,515
+1,252
+38% +$64K 0.02% 609
2025
Q1
$181K Buy
3,263
+310
+10% +$16.8K 0.02% 647
2024
Q4
$142K Buy
2,953
+444
+18% +$22.6K 0.01% 733
2024
Q3
$145K Buy
+2,509
New +$135K 0.01% 738

Other funds holding SNY

BFC Planning's SNY Position: Q3 2026 in Review

BFC Planning increased its Sanofi (SNY) stake by 0.06% in Q3 2026, buying an estimated $174 and bringing the position to 6,983 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #805.

BFC Planning first reported a position in SNY in Q3 2024 and has held it in 9 quarters since. The position peaked at $298K in Q2 2026. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • BFC Planning held 6,983 shares of Sanofi worth $288K as of Q3 2026.
  • BFC Planning bought 4 Sanofi shares in Q3 2026, an estimated $174.
  • Sanofi made up 0.01% of BFC Planning's portfolio in Q3 2026, its #805 holding.
  • BFC Planning first reported a position in Sanofi in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Sanofi position peaked at $298K in Q2 2026.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.